Public Hospital Network of Paris (Assistance Publique Hopitaux de Paris) has Selected Bruker Corporation's IVD MALDI Biotyper for MALDI-TOF-based Microbial Identification

PARIS--(BUSINESS WIRE)--At the 30th Reunion Interdisciplinaire de Chimothérapie Anti-Infectieuse (RICAI), Bruker announces that the Assistance Publique Hôpitaux de Paris (APHP) has selected Bruker´s IVD MALDI Biotyper as their exclusive MALDI-TOF mass spectrometry-based microbial identification tool. APHP is the association of all 44 public hospitals in Paris, and is the largest public health network in France. The APHP is providing medical service for the complete metropolitan area of Paris with more than ten million inhabitants.